Ultragenyx Pharma Q2 Loss Narrows; Lifts FY Revenue Guidance; Stock Up In After-hours
2/8 05:33
(RTTNews) - Ultragenyx Pharmaceutical Inc. (RARE) reported that its second quarter net loss narrowed to $131.60 million or $1.52 per share from $159.83 million or $2.25 per share in the prior year....